In the SARS-CoV2 infection, there has been an “infection-induced coagulopathy” phenomenon, resulting from hyperactivation of endothelial cells (due to the increased amount of IL-6) and increased release of tissue factor [21]. This evidence concerns the gene F3 and blood coagulation disease.